Functional Gastrointestinal Disorders: History, Pathophysiology, Clinical Features and Rome IV.

  title={Functional Gastrointestinal Disorders: History, Pathophysiology, Clinical Features and Rome IV.},
  author={Douglas A. Drossman},
  • D. Drossman
  • Published 1 May 2016
  • Medicine
  • Gastroenterology
Functional gastrointestinal disorders (FGIDs), the most common diagnoses in gastroenterology are recognized by morphological and physiological abnormalities that often occur in combination including motility disturbance, visceral hypersensitivity, altered mucosal and immune function, altered gut microbiota and altered central nervous system processing. Research on these gut-brain interaction disorders is based on using specific diagnostic criteria. The Rome Foundation has played a pivotal role… 

Figures and Tables from this paper

The Rome IV: Irritable bowel syndrome - A functional disorder.

Current Treatment Options and Therapeutic Insights for Gastrointestinal Dysmotility and Functional Gastrointestinal Disorders

The current treatment options, clinical insight on pathophysiology, therapeutic modalities, current challenges, and therapeutic clues for the clinical care and management of functional dyspepsia, gastroparesis, irritable bowel syndrome, functional constipation, and functional diarrhea are reviewed.

What Is New in Rome IV

The aim is to review the main changes in Rome IV, which has a multicultural rather than a Western-culture focus, and new FGIDs based on available evidence including reflux hypersensitivity and centrally mediated abdominal pain syndrome.

Physiological mechanisms of unexplained (functional) gastrointestinal disorders

Considerations for future research should include the role of sex hormones in regulating physiological functions and treatment responses in patients, as well as the importance of high‐level phenotyping of clinical, immune, microbial and physiological parameters in study cohorts.

How to use Rome IV criteria in the evaluation of esophageal disorders

The Rome IV criteria for esphageal DGBI, the updated algorithms for esophageal symptoms, and the multidimensional clinical profile (MDCP) are reviewed.

Functional Abdominal Pain

FGIDs are now defined as disorders of brain–gut interaction, and effective management requires a biopsychosocial approach that addresses the variability and complexity of these patients.

Concurrent functional gastrointestinal disorders in patients with inflammatory bowel disease

Management usually follows those interventions recommended for FGIDs, with certain adaptations made to allow for an altered gastrointestinal anatomy and functioning, caused by IBD.

Gut Inflammation: More Than a Peripheral Annoyance

A preclinical model of neonatal colon inflammation is utilized to examine symptoms or functions central to functional dyspepsia, specifically early satiety, discomfort, delayed gastric empting, and anxietyand depression-like behaviors.

Tangible pathologies in functional dyspepsia.




Rome II: the Functional Gastrointestinal Disorders. Diagnosis, Pathophysiology and Treatment: a Multinational Consensus

The Rome process has had a major impact, and Rome criteria are now used for the entry into most clinical trials, so that classifications must of necessity be symptom based.

Intestinal microbiota in functional bowel disorders: a Rome foundation report

A critical review of current hypotheses regarding the pathogenetic involvement of microbiota in FGID is provided and the results of microbiota-directed interventions are evaluated and clinical guidance on modulation of gut microbiota in IBS is provided.

The Role of Food in the Functional Gastrointestinal Disorders: Introduction to a Manuscript Series

  • W. Chey
  • Medicine
    The American Journal of Gastroenterology
  • 2013
In a series of evidence-based manuscripts produced by the Rome Foundation Working Group on the role of food in FGIDs, comprehensive reviews of the physiological changes associated with nutrient intake, and the respective roles of carbohydrates, fiber, protein, and fats are provided.

Functional bowel disorders and functional abdominal pain

A committee consensus approach, including criticism from multinational expert reviewers, was used to revise the diagnostic criteria and update diagnosis and treatment recommendations, based on research results.

Pathogenesis of IBS: role of inflammation, immunity and neuroimmune interactions

Functional and anatomical evidence for abnormal neuroimmune interactions has been found in patients with IBS and the link between immune alterations and severity of gastrointestinal symptoms and the positive effect of anti-inflammatory treatments in IBS further highlight the relevance of neuro immune interactions in this condition.

Genetic approaches to functional gastrointestinal disorders.

A better understanding of the genetic architecture of functional gastrointestinal disorders would help to better identify their complex biology and explain the common comorbidity with other disorders of persistent pain, mood, and affect, as well as possibly make it possible to identify subgroups of patients who respond to customized therapies.

The functional gastrointestinal disorders and the Rome III process.

Two important processes have occurred to legitimize these conditions, and to increase attention toward the research and clinical care of patients with functional gastrointestinal disorders (FGID), a shift in conceptualizing these disorders from a disease-based, reductionistic model, to a more integrated, biopsychosocial model of illness.

Dietary Proteins and Functional Gastrointestinal Disorders

The role of dietary proteins in the symptoms and pathophysiology of FGIDs is summarized, which suggests a heterogeneous condition with some features of celiac disease but often categorized as FGIDs, including IBS.

Basic and clinical aspects of visceral hyperalgesia.

Dietary Lipids and Functional Gastrointestinal Disorders

Large studies are needed to evaluate dietary patterns and eating behavior in patients with functional gastrointestinal disorders, with often-conflicting outcomes, and the role of targeted dietary interventions for the relief of symptoms to develop personalized, cost-effective treatment approaches.